Dermagnostix

medical devices

About

Dermagnostix is a medtech company based in Freiburg, Germany, specializing in innovative molecular diagnostic solutions for dermatology. Founded in 2021 as a spin-off from the Hahn-Schickard Institute, Helmholtz Zentrum München, and the Technical University of Munich, the company focuses on bridging the gap between advanced dermatological therapies and traditional diagnostic methods. The flagship product, PsorX-LabDisk, is the first molecular test that differentiates between psoriasis and eczema using gene expression markers. This test is performed on a disposable LabDisk cartridge, allowing for quick and reliable results at the point of need. Dermagnostix also offers a modular microfluidic platform and fluorescence detection technology, enhancing their capabilities in diagnostics and research. Their target customers include dermatologists, diagnostic laboratories, and research organizations, all seeking accurate and rapid molecular diagnostics for skin health. The company aims to advance dermatology diagnostics and improve patient outcomes through objective molecular results.

Technologies

Outlook Hubspot Mobile Friendly Nginx WordPress.org Google Font API Google Tag Manager IoT

Keywords

molecular diagnostics dermatology biomarkers lab automation microfluidics psoriasis eczema medical equipment manufacturing medical equipment and supplies manufacturing clinical workflow integration pharmaceuticals services patient care skin disease biomarkers molecular pattern diagnostics fluorescence detector technology ce-ivd plug-and-play system dermagnostix labdisk technology skin biopsy sample processing patternx molecular patterns gene expression analysis molecular pathology skin inflammation profiling diagnostic accuracy personalized medicine clinical decision support in-house production of analyzer point-of-care b2b

Location

Freiburg, Baden-Wuerttemberg, Germany

Related Companies

Companies in the same industry